NASDAQ:PRPO Precipio (PRPO) Stock Price, News & Analysis $7.32 +0.97 (+15.28%) Closing price 05/2/2025 03:59 PM EasternExtended Trading$7.18 -0.14 (-1.84%) As of 05/2/2025 05:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Precipio Stock (NASDAQ:PRPO) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Precipio alerts:Sign Up Key Stats Today's Range$6.07▼$7.3250-Day Range$4.50▼$7.7052-Week Range$3.90▼$10.74Volume8,684 shsAverage Volume9,088 shsMarket Capitalization$11.01 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewPrecipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut.Read More… Precipio Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks14th Percentile Overall ScorePRPO MarketRank™: Precipio scored higher than 14% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Precipio. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Precipio is -4.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Precipio is -4.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioPrecipio has a P/B Ratio of 0.72. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Precipio's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.58% of the float of Precipio has been sold short.Short Interest Ratio / Days to CoverPrecipio has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Precipio has recently increased by 96.12%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldPrecipio does not currently pay a dividend.Dividend GrowthPrecipio does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted1.58% of the float of Precipio has been sold short.Short Interest Ratio / Days to CoverPrecipio has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Precipio has recently increased by 96.12%, indicating that investor sentiment is decreasing significantly. News and Social Media0.6 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for Precipio this week, compared to 0 articles on an average week.Search Interest2 people have searched for PRPO on MarketBeat in the last 30 days. Company Ownership2.5 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, Precipio insiders have bought more of their company's stock than they have sold. Specifically, they have bought $474.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders13.30% of the stock of Precipio is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 10.45% of the stock of Precipio is held by institutions.Read more about Precipio's insider trading history. Receive PRPO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Precipio and its competitors with MarketBeat's FREE daily newsletter. Email Address PRPO Stock News HeadlinesPrecipio Announces Q1-2025 Shareholder Update CallMay 1, 2025 | globenewswire.comPrecipio Stock Price, Quotes and Forecasts | NASDAQ:PRPO | BenzingaApril 26, 2025 | benzinga.comThe Man I Turn to In Times Like ThisA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.” Tilson just released a new prediction that runs counter to what mainstream finance is telling you.May 5, 2025 | Stansberry Research (Ad)Precipio trading halted, volatility trading pauseApril 24, 2025 | markets.businessinsider.comEarnings call transcript: Precipio Q4 2024 sees revenue growth, strategic shiftsApril 2, 2025 | investing.comPrecipio Inc (PRPO) Q4 2024 Earnings Call Highlights: Break-Even Achieved and Strategic Growth ...April 2, 2025 | finance.yahoo.comPrecipio, Inc. (NASDAQ:PRPO) Q4 2024 Earnings Call TranscriptApril 1, 2025 | msn.comPrecipio Reports Positive Q4 Financial ResultsApril 1, 2025 | tipranks.comSee More Headlines PRPO Stock Analysis - Frequently Asked Questions How have PRPO shares performed this year? Precipio's stock was trading at $5.54 at the beginning of the year. Since then, PRPO stock has increased by 32.1% and is now trading at $7.32. View the best growth stocks for 2025 here. How were Precipio's earnings last quarter? Precipio, Inc. (NASDAQ:PRPO) posted its quarterly earnings data on Thursday, March, 27th. The biotechnology company reported ($0.23) EPS for the quarter, missing the consensus estimate of $0.74 by $0.97. The biotechnology company earned $5.45 million during the quarter, compared to the consensus estimate of $8.01 million. Precipio had a negative trailing twelve-month return on equity of 34.01% and a negative net margin of 17.23%. Read the conference call transcript. When did Precipio's stock split? Precipio shares reverse split on the morning of Friday, September 22nd 2023. The 1-20 reverse split was announced on Friday, September 22nd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, September 22nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. How do I buy shares of Precipio? Shares of PRPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Precipio own? Based on aggregate information from My MarketBeat watchlists, some other companies that Precipio investors own include NVIDIA (NVDA), Meta Platforms (META), CymaBay Therapeutics (CBAY), Advanced Micro Devices (AMD), Broadcom (AVGO), CrowdStrike (CRWD) and GE Aerospace (GE). Company Calendar Last Earnings3/27/2025Today5/05/2025Next Earnings (Estimated)5/13/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Analytical instruments Sub-IndustryMeasuring And Control Equipment Current SymbolNASDAQ:PRPO CIK1043961 Webwww.precipiodx.com Phone(203) 787-7888Fax402-452-5401Employees60Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($2.94) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-5,850,000.00 Net Margins-17.23% Pretax Margin-17.23% Return on Equity-34.01% Return on Assets-25.27% Debt Debt-to-Equity Ratio0.02 Current Ratio0.73 Quick Ratio0.60 Sales & Book Value Annual Sales$18.53 million Price / Sales0.59 Cash FlowN/A Price / Cash FlowN/A Book Value$10.16 per share Price / Book0.72Miscellaneous Outstanding Shares1,504,000Free Float1,285,000Market Cap$11.01 million OptionableNo Data Beta1.04 A Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free Report This page (NASDAQ:PRPO) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredU.S. Stock Market Now on Verge of CollapseThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Precipio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Precipio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.